Gilead Sciences (GILD) Assets (2009 - 2026)
Gilead Sciences (GILD) recorded Assets of $51.41 billion in Q3 2026, down 12.2% from $58.53 billion a year earlier but up 4.1% from the prior quarter.
Analysis
Gilead Sciences (GILD) Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Gilead Sciences reported Assets of $59.02 billion, unchanged from FY2024.
- Annual Assets has a five-year compound annual growth rate of -2.9% (FY2020 to FY2025).
- Across earlier years, Assets came in at $59 billion in FY2024 (-5.0%), $62.13 billion in FY2023 (-1.7%), $63.17 billion in FY2022 (-7.0%) and $67.95 billion in FY2021 (-0.7%).
- Quarterly Assets has ranged from $49.36 billion in Q2 2026 to $67.95 billion in Q4 2021 over the past five years.
- On a year-over-year basis, Assets has declined for three consecutive quarters, with an average decline of 2.2% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 7.4% in Q3 2025, against a decline of 14.0% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $49.36 billion (Q2 2026), $56.28 billion (Q1 2026) and $59.02 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | 2.15 Mn |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 148.07 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 197.43 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 147.68 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 132.77 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 96.05 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 51.41 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | 94.88 Bn |
| 10 | Pfizer | 156.44 Bn | 103.79 Bn | 12.56 Bn | 205.00 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 51.41 Bn |
| Jun 30, 2026 | 49.36 Bn |
| Mar 31, 2026 | 56.28 Bn |
| Dec 31, 2025 | 59.02 Bn |
| Sep 30, 2025 | 58.53 Bn |
| Jun 30, 2025 | 55.72 Bn |
| Mar 31, 2025 | 56.43 Bn |
| Dec 31, 2024 | 59.00 Bn |
| Sep 30, 2024 | 54.53 Bn |
| Jun 30, 2024 | 53.58 Bn |
| Mar 31, 2024 | 56.29 Bn |
| Dec 31, 2023 | 62.13 Bn |
| Sep 30, 2023 | 62.37 Bn |
| Jun 30, 2023 | 62.34 Bn |
| Mar 31, 2023 | 61.88 Bn |
| Dec 31, 2022 | 63.17 Bn |
| Sep 30, 2022 | 62.56 Bn |
| Jun 30, 2022 | 62.87 Bn |
| Mar 31, 2022 | 63.08 Bn |
| Dec 31, 2021 | 67.95 Bn |
API Access
Gilead Sciences Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=GILD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();